Cipla reported 23.56 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cara Therapeutics 27.77 117.09 Sep/2021
Cipla 23.56 4.18 Mar/2026
Dr.Reddys Laboratories 23.73 4.04 Mar/2026
Esperion Therapeutics 129.79 129 Dec/2024
Sun Pharmaceuticals 39.44 5.7 Dec/2025
TherapeuticsMD 0.75 3.3 Mar/2023
UPL 26.28 9.18 Mar/2026